Eligibility Parkinson's Disease NCT01590056

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
clinically definite pd treated / candidates for treatment with dbs (patients with advanced idiopathic pd who are deemed appropriate for dbs surgery).
Description

ID.1

Data type

boolean

patients will be included in the study irrespective of whether a diagnosis of major depression (mild to moderate but not severe mdd) is fulfilled at baseline. patients without depression will be monitored in the study for evidence of treatment emergent depression. patients with depression will be monitored for antidepressant effects of stimulation change.
Description

ID.2

Data type

boolean

age 40-75 years
Description

ID.3

Data type

boolean

male or female.
Description

ID.4

Data type

boolean

competent and willing to give written informed consent.
Description

ID.5

Data type

boolean

Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
significant suicidal risk [hamilton depression scale item 3 (suicide) >2].
Description

ID.6

Data type

boolean

comorbidity with any psychotic disorder, bipolar disorder, post traumatic stress disorder (ptsd), eating disorder.
Description

ID.7

Data type

boolean

lifetime history of substance or alcohol dependence or of abuse in the preceding 12 months
Description

ID.8

Data type

boolean

significant cognitive decline, as measured by addenbrooke's cognitive examination (ace) and the frontal assessment battery (fab).
Description

ID.9

Data type

boolean

Similar models

Eligibility Parkinson's Disease NCT01590056

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
clinically definite pd treated / candidates for treatment with dbs (patients with advanced idiopathic pd who are deemed appropriate for dbs surgery).
boolean
ID.2
Item
patients will be included in the study irrespective of whether a diagnosis of major depression (mild to moderate but not severe mdd) is fulfilled at baseline. patients without depression will be monitored in the study for evidence of treatment emergent depression. patients with depression will be monitored for antidepressant effects of stimulation change.
boolean
ID.3
Item
age 40-75 years
boolean
ID.4
Item
male or female.
boolean
ID.5
Item
competent and willing to give written informed consent.
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
significant suicidal risk [hamilton depression scale item 3 (suicide) >2].
boolean
ID.7
Item
comorbidity with any psychotic disorder, bipolar disorder, post traumatic stress disorder (ptsd), eating disorder.
boolean
ID.8
Item
lifetime history of substance or alcohol dependence or of abuse in the preceding 12 months
boolean
ID.9
Item
significant cognitive decline, as measured by addenbrooke's cognitive examination (ace) and the frontal assessment battery (fab).
boolean